FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1078.931

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113762.1.4.1078.931
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.931/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.931
Version20240709
Statusactive
Date2024-07-09T01:07:16-04:00
NameLiraglutideMeds
TitleLiraglutide meds
Realmus
Authorityhl7
Purpose(Clinical Focus: Medications containing liraglutide, including combination medications and medications with indications other than type 2 diabetes mellitus.),(Data Element Scope: RxCUIs at product level (SCD, GPCK, SBD, BPCK)),(Inclusion Criteria: Valid, prescribable RxCUIs (including retried RxCUIs) with liraglutide as ingredient),(Exclusion Criteria: Invalidated RxCUIs)

Resources that use this resource

ValueSet
2.16.840.1.113762.1.4.1078.933T2DM meds benefitting ASCVD
2.16.840.1.113762.1.4.1078.934T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min
2.16.840.1.113762.1.4.1078.935T2DM meds benefitting CKD stage 5

Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1078.931",
  "meta": {
    "versionId": "7",
    "lastUpdated": "2024-07-09T01:07:16.000-04:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Optum Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-07-09"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-07-09"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.931",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1078.931"
    }
  ],
  "version": "20240709",
  "name": "LiraglutideMeds",
  "title": "Liraglutide meds",
  "status": "active",
  "date": "2024-07-09T01:07:16-04:00",
  "publisher": "Optum Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: Medications containing liraglutide, including combination medications and medications with indications other than type 2 diabetes mellitus.),(Data Element Scope: RxCUIs at product level (SCD, GPCK, SBD, BPCK)),(Inclusion Criteria: Valid, prescribable RxCUIs (including retried RxCUIs) with liraglutide as ingredient),(Exclusion Criteria: Invalidated RxCUIs)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "1598268",
            "display": "3 ML liraglutide 6 MG/ML Pen Injector [Saxenda]"
          },
          {
            "code": "1860167",
            "display": "3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector"
          },
          {
            "code": "1860172",
            "display": "3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector [Xultophy]"
          },
          {
            "code": "897122",
            "display": "3 ML liraglutide 6 MG/ML Pen Injector"
          },
          {
            "code": "897126",
            "display": "3 ML liraglutide 6 MG/ML Pen Injector [Victoza]"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:d61c8b7b-961c-4bad-9ca8-c5975e68564d",
    "timestamp": "2025-05-23T18:02:38-04:00",
    "total": 5,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1598268",
        "display": "3 ML liraglutide 6 MG/ML Pen Injector [Saxenda]"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1860167",
        "display": "3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1860172",
        "display": "3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector [Xultophy]"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "897122",
        "display": "3 ML liraglutide 6 MG/ML Pen Injector"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "897126",
        "display": "3 ML liraglutide 6 MG/ML Pen Injector [Victoza]"
      }
    ]
  }
}